These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35249863)

  • 1. [Economic aspects in the care of patients with new oral anticancer drugs: findings from the AMBORA trial].
    Dürr P; Schlichtig K; Krebs S; Schramm A; Schötz L; Fromm MF; Dörje F
    Z Evid Fortbild Qual Gesundhwes; 2022 Apr; 169():84-93. PubMed ID: 35249863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of Drug Wastage From Dose Modification and Discontinuation of Oral Anticancer Drugs.
    Lam M; Olivier T; Haslam A; Tuia J; Prasad V
    JAMA Oncol; 2023 Sep; 9(9):1238-1244. PubMed ID: 37471095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial.
    Dürr P; Meier F; Schlichtig K; Schramm A; Schötz L; Fromm MF; Dörje F
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents.
    Dürr P; Schlichtig K; Kelz C; Deutsch B; Maas R; Eckart MJ; Wilke J; Wagner H; Wolff K; Preuß C; Brückl V; Meidenbauer N; Staerk C; Mayr A; Fietkau R; Goebell PJ; Kunath F; Beckmann MW; Mackensen A; Neurath MF; Pavel M; Dörje F; Fromm MF
    J Clin Oncol; 2021 Jun; 39(18):1983-1994. PubMed ID: 33822650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial impact of oral chemotherapy wastage on society and the patient.
    Monga V; Meyer C; Vakiner B; Clamon G
    J Oncol Pharm Pract; 2019 Jun; 25(4):824-830. PubMed ID: 29575989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication wasted - Contents and costs of medicines ending up in household garbage.
    Vogler S; de Rooij RHPF
    Res Social Adm Pharm; 2018 Dec; 14(12):1140-1146. PubMed ID: 29452743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a standardised pharmacist check of medical orders prior to preparation of anticancer drugs to reduce drug wastage.
    Yamada H; Kobayashi R; Shimizu S; Yamada Y; Ishida M; Shimoda H; Kato-Hayashi H; Fujii H; Iihara H; Tanaka H; Suzuki A
    Int J Clin Pract; 2020 Apr; 74(4):e13464. PubMed ID: 31830345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acceptance of an oncologic addendum for the application of the German Standardized Medication Plan in oral anticancer drug therapy].
    Barnert AK; Hofmann P; Liekweg A; Kunze A; Scheid C; Hermes-Moll K; Osburg S; Jaehde U
    Z Evid Fortbild Qual Gesundhwes; 2022 Dec; 175():29-42. PubMed ID: 36372643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wastage of medicines and its financial impact on the healthcare system in the Czech Republic.
    Smejkalová JKJKJKTAL
    Ceska Slov Farm; 2018 Dec; 67(5-6):192-199. PubMed ID: 30871324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated Cost and Savings in a Patient Management Program for Oral Oncology Medications: Impact of a Split-Fill Component.
    Staskon FC; Kirkham HS; Pfeifer A; Miller RT
    J Oncol Pract; 2019 Oct; 15(10):e856-e862. PubMed ID: 31465250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial audit of wastage of anticancer drugs: Pilot study from a tertiary care center in India.
    D'Souza VR; Palatty PL; George T; Adnan M; Rao S; Baliga MS
    Indian J Cancer; 2019; 56(2):146-150. PubMed ID: 31062734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK interventions to control medicines wastage: a critical review.
    White KG
    Int J Pharm Pract; 2010 Jun; 18(3):131-40. PubMed ID: 20509346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs: The ROAD Study.
    Smale EM; van den Bemt BJF; Heerdink ER; Desar IME; Egberts TCG; Bekker CL;
    JAMA Oncol; 2024 Jan; 10(1):87-94. PubMed ID: 37971730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taking stock of medication wastage: Unused medications in US households.
    Law AV; Sakharkar P; Zargarzadeh A; Tai BW; Hess K; Hata M; Mireles R; Ha C; Park TJ
    Res Social Adm Pharm; 2015; 11(4):571-8. PubMed ID: 25487420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective, multicohort analysis of the Clinical Practice Research Datalink (CPRD) to determine differences in the cost of medication wastage, dispensing fees and prescriber time of issuing either short (<60 days) or long (≥60 days) prescription lengths in primary care for common, chronic conditions in the UK.
    Doble B; Payne R; Harshfield A; Wilson ECF
    BMJ Open; 2017 Dec; 7(12):e019382. PubMed ID: 29208621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A real-world analysis of cancer drug wastage due to oversized vials.
    Liran O; Prus J; Gordon N; Almog V; Gruenewald T; Goldstein DA
    J Am Pharm Assoc (2003); 2018; 58(6):643-646. PubMed ID: 30017368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of KW-ANOVA statistics to generate evidence for cytotoxic drug wastage induced financial burden among cancer patients: A clinical pharmacist observation.
    Jyoti K; Manjula G; Ganachari MS
    J Oncol Pharm Pract; 2020 Oct; 26(7):1559-1565. PubMed ID: 31948346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA Study.
    Schlichtig K; Dürr P; Dörje F; Fromm MF
    Clin Pharmacol Ther; 2021 Oct; 110(4):1075-1086. PubMed ID: 34118065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.